Expert consensus document on the use of antiplatelet agents. The task force on the use of antiplatelet agents in patients with atherosclerotic cardiovascular disease of the European society of cardiology.

Expert consensus document on the use of antiplatelet agents. The task force on the use of antiplatelet agents in patients with atherosclerotic cardiovascular disease of the European society of cardiology.

Bibliographic Details
Main Authors:	Patrono, C, Bachmann, F, Baigent, C, Bode, C, De Caterina, R, Charbonnier, B, Fitzgerald, D, Hirsh, J, Husted, S, Kvasnicka, J, Montalescot, G, García Rodríguez, L, Verheugt, F, Vermylen, J, Wallentin, L, Priori, S, Garcia, A, Blanc, J, Budaj, A, Cowie, M, Dean, V, Deckers, J, Fernández Burgos, E, Lekakis, J, Lindahl, B
Format:	Journal article
Language:	English
Published:	2004

Similar Items

[Expert consensus document on the use of antiplatelet agents].
by: Patrono, C, et al.
Published: (2004)

[Expert consensus document on the use of antiplatelet agents].
by: Patrono, C, et al.
Published: (2004)

Antiplatelet agents for the treatment and prevention of atherothrombosis.
by: Patrono, C, et al.
Published: (2011)

Antiplatelet agents for the treatment and prevention of coronary atherothrombosis
by: Patrono, C, et al.
Published: (2017)

Antiplatelet therapy: aspirin for asymptomatic atherosclerosis?
by: Patrono, C, et al.
Published: (2010)

Antiplatelet drugs: American College of Chest Physicians Evidence-Based Clinical Practice Guidelines (8th Edition).
by: Patrono, C, et al.
Published: (2008)

Statement on Antiplatelet Agents and Anticoagulants in Cardiology - 2019
by: Carlos V. Serrano Jr., et al.

Antiplatelet agents: an overview
by: Asma Haffouz, et al.
Published: (2023-01-01)

Newer agents in antiplatelet therapy: a review
by: Yeung J, et al.
Published: (2012-06-01)

New antiplatelet agents and prosthetic heart valves.
by: Timperley, J, et al.
Published: (2002)

Antiplatelet agents in stroke prevention.
by: Peto, R
Published: (1988)

Patterns of antiplatelet agent use in the US
by: Vijay Kanakadandi, et al.
Published: (2015-06-01)

Aspirin and other antiplatelet agents in the secondary and primary prevention of cardiovascular disease.
by: Hennekens, C, et al.
Published: (1989)

Assessing Pharmacodynamic Effects of Antiplatelet Agents With Different Mechanisms of Action
by: David J. Schneider, et al.
Published: (2021-05-01)

Antiplatelet agents for the treatment of adults with COVID-19
by: Fischer, A-L, et al.
Published: (2023)

Role of sodium tungstate as a potential antiplatelet agent
by: Fernández-Ruiz R, et al.
Published: (2015-05-01)

TRIALS OF ANTIPLATELET THERAPY - REPLY
by: Baigent, C, et al.
Published: (1994)

Antiplatelet therapy for thromboprophylaxis: the need for careful consideration of the evidence from randomised trials. Antiplatelet Trialists' Collaboration.
by: Collins, R, et al.
Published: (1994)

Antiplatelet agents in perioperative noncardiac surgeries: to maintain or to suspend?
by: Borges JMDM, et al.
Published: (2018-10-01)

Antiplatelet/anticoagulant agents and chronic subdural hematoma in the elderly.
by: Pasquale De Bonis, et al.
Published: (2013-01-01)

Preparations from selected cucurbit vegetables as antiplatelet agents
by: Agata Rolnik, et al.
Published: (2021-11-01)

Lumbar puncture in patients using anticoagulants and antiplatelet agents
by: Renan Domingues, et al.
Published: (2016-08-01)

Antiplatelet Agents Inhibit The Generation Of Platelet-Derived Microparticles
by: Alice Giacomazzi, et al.
Published: (2016-09-01)

Prevention of Peptic Ulcer Associated with Aspirin and Antiplatelet Agent
by: Ji Yong Ahn
Published: (2020-11-01)

Risk Factors for Severe Bleeding Complications in Glaucoma Surgery and the Role of Antiplatelet or Anticoagulant Agents
by: Lauermann P, et al.
Published: (2022-04-01)

Short dual antiplatelet therapy and dual antiplatelet therapy de-escalation after primary percutaneous intervention: For whom and how
by: Marie Muthspiel, et al.
Published: (2022-11-01)

Antiplatelet Agents Affecting GPCR Signaling Implicated in Tumor Metastasis
by: Gianenrico Rovati, et al.
Published: (2022-02-01)

Antiplatelet Agents for Cancer Prevention: Current Evidences and Continuing Controversies
by: Corinne Frere, et al.
Published: (2019-10-01)

Risk of Gastrointestinal Bleed and Endoscopic Procedures on Antiplatelet and Antithrombotic Agents
by: Partha Pal, et al.
Published: (2019-01-01)

PAR-1 inhibitor antiplatelet agents: Performance below par?
by: Arun Natarajan, et al.
Published: (2012-11-01)

Potential role for TCD-directed antiplatelet agents in symptomatic carotid artery dissection.
by: Imray, C, et al.
Published: (2006)

Antiplatelet and anticoagulant therapy in elective percutaneous coronary intervention
by: Verheugt Freek WA, et al.
Published: (2001-05-01)

Predicting Chronic Subdural Hematoma Recurrence and Stroke Outcomes While Withholding Antiplatelet and Anticoagulant Agents
by: Mario Zanaty, et al.
Published: (2020-01-01)

ANTIPLATELET AGENTS IN THE TREATMENT AND SECONDARY PREVENTION OF ISCHEMIC STROKE (REVIEW OF LITERATURE)
by: E. Y. Kitaeva, et al.
Published: (2017-04-01)

Preparation and Evaluation of 6-Gingerol Derivatives as Novel Antioxidants and Antiplatelet Agents
by: Sara H. H. Ahmed, et al.
Published: (2023-03-01)

Effect of antiplatelet agents on Escherichia coli sepsis mechanisms: A review
by: Antoine Mariotti, et al.
Published: (2022-12-01)

PREVENTION OF ISCHEMIC STROKE Antiplatelet Agents, Carotid Endarterectomy and Angioplasty and Stenting
by: Harold P. Adams
Published: (2008-12-01)

Platelet-Derived Extracellular Vesicles as Target of Antiplatelet Agents. What Is the Evidence?
by: Francesco Taus, et al.
Published: (2019-11-01)

Efficacy and Safety of Antiplatelet Agents for Adult Patients With Ischemic Moyamoya Disease
by: Fei Ye, et al.
Published: (2021-01-01)

Antiplatelet agents and proton pump inhibitors &ndash; personalizing treatment
by: Eugene Lin, et al.
Published: (2010-06-01)